Somatropin biosimilar - BiosidusAlternative Names: Growmax™; HHT; Somatrop; Somatropin Biosidus Injection
Latest Information Update: 20 Sep 2013
$50 / €47 *
At a glance
- Originator Biosidus S.A.
- Class Growth hormones; Hormonal replacements
- Mechanism of Action Somatotropin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Somatotropin deficiency
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 14 May 2012 Launched for Somatotropin deficiency in Brazil (SC)
- 10 Aug 2011 Launched for Somatotropin deficiency in Argentina (SC)